PR Newswire: news distribution, targeting and monitoring
2014
See more news releases in Banking & Financial Services  | Legal Issues

Faruqi & Faruqi, LLP is Investigating Chemed Corporation on Behalf of its Shareholders - CHE

Share with Twitter Share with LinkedIn

NEW YORK, Aug. 27, 2013 /PRNewswire/ -- Faruqi & Faruqi, LLP, a national law firm concentrating on investor rights, consumer rights and the enforcement of federal antitrust laws, is investigating potential claims against the Board of Directors of Chemed Corporation ("Chemed" or the "Company") (NYSE: CHE) concerning possible breaches of fiduciary duty and other violations of law.  The investigation concerns actions by Chemed's Board of Directors that have allegedly caused the Company to violate the False Claims Act ("FCA").

(Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO )

Specifically, on May 2, 2013 the Department of Justice announced that it had filed a suit against Chemed for violating the FCA by billing Medicare for excessively costly services and wrongfully admitting patients for hospice care.  The government's complaint alleges that Chemed routinely billed Medicare for more costly crisis care services when certain patients did not need crisis care services, often submitted for reimbursement from Medicare for certain services that Chemed subsidiaries did not even provide, and habitually billed Medicare when Chemed subsidiaries provided inappropriate medical care. The complaint alleges that Chemed knowingly caused the submission of false claims to Medicare in violation of the FCA. 

Shareholders interested in seeking to recover damages on behalf of Chemed and to implement corporate governance measures designed to prevent future misconduct should contact the firm.

Request more information now by clicking here: www.faruqilaw.com/CHE.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action and derivative litigation.  The firm is focused on providing exemplary legal services in the areas of securities, shareholder, antitrust and consumer litigation, through all phases of litigation.  The firm has an experienced trial team which has achieved significant victories on behalf of the firm's clients.

If you hold Chemed shares and you would like to discuss your legal rights, visit www.faruqilaw.com/CHE.  You can also contact us by calling Michael J. Hynes free at 877-247-4292 or at 215-277-5770 or by sending an e-mail to mhynes@faruqilaw.com .

Contact:

Faruqi & Faruqi, LLP
Michael J. Hynes, Esq.
101 Greenwood Avenue Suite 600
Jenkintown, PA 19046
Telephone: (877) 247-4292 or (215) 277-5770
E-mail: mhynes@faruqilaw.com

(NYSE: CHE)

Attorney Advertising. (C) 2013 Faruqi & Faruqi, LLP.  The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).  Prior results do not guarantee or predict a similar outcome with respect to any future matter.  We welcome the opportunity to discuss your particular case.  All communications will be treated in a confidential manner.

 

SOURCE Faruqi & Faruqi, LLP



RELATED LINKS
http://www.faruqilaw.com

Featured Video

Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.

View and download archived video content distributed by MultiVu on The Digital Center.

Share with Twitter Share with LinkedIn
 

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

 
 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

 
 

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.

 

Online Member Center

Not a Member?
Click Here to Join
Login
Search News Releases
Advanced Search
Search
  1. PR Newswire Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
  5. Send a News Release